Advanced Glycation: A Novel Outlook on Atherosclerosis

E-ISSN： 1873-4286|13|36|3681-3687

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.36, 2007-12, pp. : 3681-3687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite

Food-Derived Advanced Glycation end Products (AGEs): A Novel Therapeutic Target for Various Disorders

Current Pharmaceutical Design, Vol. 13, Iss. 27, 2007-09 ,pp. : 2832-2836

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W Jenkins Alicia J Cooper Mark E

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite

The Road to Advanced Glycation End Products: A Mechanistic Perspective

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1653-1671

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Diabetic Neuropathy

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 953-961

Bentham Science Publishers

Access to resources Recommend Favorite